Third-Generation-Blockers Stimulate Nitric Oxide Release From Endothelial Cells Through ATP Efflux

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased Nitric Oxide Bioavailability in Endothelial Cells Contributes to the Pleiotropic Effect of Cerivastatin

  2002cited by this paper
• Nebivolol Induces Calcium‐Independent Signaling in Endothelial Cells by a Possible &bgr;‐Adrenergic Pathway

  2001cited by this paper
• Oxidative inactivation of nitric oxide and endothelial dysfunction in stroke-prone spontaneous hypertensive rats.

  2001cited by this paper
• Nebivolol: Endothelium‐Mediated Vasodilating Effect

  2001cited by this paper
• Cyclic GMP‐dependent relaxation of isolated rat renal glomeruli induced by extracellular ATP

  2001cited by this paper
• Nebivolol induces NO-mediated relaxations of rat small mesenteric but not of large elastic arteries.

  2000cited by this paper
• Disparate effects of carvedilol versus metoprolol treatment of stroke-prone spontaneously hypertensive rats on endothelial function of resistance arteries.

  2000cited by this paper
• Inositol phosphate metabolism and nitric-oxide synthase activity in endothelial cells are involved in the vasorelaxant activity of nebivolol.

  2000cited by this paper
• Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol.

  2000cited by this paper
• Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production.

  2000cited by this paper
• 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

  1999cited by this paper
• Effects of vasodilatory beta-adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney.

  1999cited by this paper
• Potential Functional Roles of Extracellular ATP in Kidney and Urinary Tract

  1998cited by this paper
• Direct Demonstration of Mechanically Induced Release of Cellular UTP and Its Implication for Uridine Nucleotide Receptor Activation*

  1997cited by this paper
• Cardiovascular pharmacology of purines.

  1997cited by this paper
• Modulation by low sodium intake of glomerular response to cicletanine and atrial natriuretic factor

  1997cited by this paper
• P2U-purinergic receptor activation mediates inhibition of cAMP accumulation in cultured renal mesangial cells.

  1995cited by this paper
• Integrin receptors and function on cultured glomerular endothelial cells.

  1993cited by this paper
• Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor

  1992cited by this paper
• Contraction and relaxation of rat aorta in response to ATP.

  1991cited by this paper

• Impact of Virgin Coconut Oil and Carvedilol on Neurobehaviour, Apoptotic and Inflammatory Brain Markers in Doxorubicin Treated Mice

  2023cites this paper
• Updates on Pharmacologic Management of Microvascular Angina

  2022cites this paper
• P2Y11 Agonism Prevents Hypoxia/Reoxygenation- and Angiotensin II-Induced Vascular Dysfunction and Intimal Hyperplasia Development

  2021cites this paper
• Oxidative Stress in Ischemic Heart Disease

  2020cites this paper
• Endothelial dysfunction and glycocalyx shedding in heart failure: insights from patients receiving cardiac resynchronisation therapy

  2019cites this paper
• A nanomedical approach to understanding the mechanism of endothelial function and dysfunction-Clinical implications 1

  2019cites this paper
• Falla cardíaca en pacientes pediátricos. Fisiopatología y tratamiento. Parte II

  2018cites this paper
• Propranolol versus carvedilol for the primary prophylaxis of variceal bleeding: a proposed multicenter, randomized, double-blind trial

  2017cites this paper
• Synthesis, biological evaluation and structure-activity relationships of new phthalazinedione derivatives with vasorelaxant activity.

  2014cites this paper
• Angiostatin inhibits endothelial MMP-2 and MMP-14 expression: a hypoxia specific mechanism of action.

  2013cites this paper
• Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation

  2010cites this paper
• Nebivolol might be Beneficial in Osteoporosis Treatment: A Hypothesis

  2009cites this paper
• Effects of Antihypertensive Drugs on Alcohol-Induced Functional Responses of Cultured Human Endothelial Cells

  2008cites this paper